Minerva Neurosciences (NERV) Change in Accrued Expenses (2013 - 2026)
Minerva Neurosciences' Change in Accrued Expenses came in at -$1.04 million for Q2 2026, compared with $324,836 a year earlier.
Powered by 
Analysis
Minerva Neurosciences (NERV) Change in Accrued Expenses (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Minerva Neurosciences reported Change in Accrued Expenses of -$325,874; for FY2025, it was $317,446.
- Going back by year, Change in Accrued Expenses was -$306,097 in FY2024, $1.13 million in FY2023, -$557,830 in FY2022 and -$1.09 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Change in Accrued Expenses since Q4 2024.
- Year-over-year, Change in Accrued Expenses increased in two of the last four quarters, with growth averaging 201.6%.
- The fastest year-over-year change in Change in Accrued Expenses over five years came in Q1 2026 (growth of 918.3%), and the weakest in Q3 2025 (a decline of 89.1%).
- Business Quant data shows NERV's Change in Accrued Expenses at $796,544 (Q1 2026), -$145,868 (Q4 2025) and $60,255 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Minerva Neurosciences | 124.09 Mn | -188.49 Mn | - | 462,263.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 462,263.00 |
| Jun 30, 2026 | -1.04 Mn |
| Mar 31, 2026 | 796,544.00 |
| Dec 31, 2025 | -145,868.00 |
| Sep 30, 2025 | 60,255.00 |
| Jun 30, 2025 | 324,836.00 |
| Mar 31, 2025 | 78,223.00 |
| Dec 31, 2024 | -2.70 Mn |
| Sep 30, 2024 | 554,787.00 |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | -139,870.00 |
| Dec 31, 2023 | -419,493.00 |
| Sep 30, 2023 | 345,035.00 |
| Jun 30, 2023 | 68,892.00 |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | -1.26 Mn |
| Sep 30, 2022 | -225,228.00 |
| Jun 30, 2022 | 227,681.00 |
| Mar 31, 2022 | 695,779.00 |
| Dec 31, 2021 | -916,512.00 |
API Access
Minerva Neurosciences Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();